Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prime-Boost Schedules of 2013 and 2017 A/H7N9 Vaccines
NCT03589807Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Aug 2018
- Primary completion
- Jun 2020
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of monovalent inactivated influenza A/H7N9 virus vaccine, 2013 A/H7N9 inactivated influenza vaccine in Avian Influenza (AI), sponsored by National Institute of Allergy and Infectious Diseases. Started Aug 2018; status: completed.
02
Drugs
monovalent inactivated influenza A/H7N9 virus vaccine2013 A/H7N9 inactivated influenza vaccine
03
Conditions
Avian Influenza (AI)
Beyond the preview
Go deeper on NCT03589807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03589807.